
Alnylam Pharmaceuticals, Inc.
USD292.58
+6.46 (+2.26%)
CEO
Yvonne L. Greenstreet
IPO Date
2004-06-01
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$284.48
Prev. Close
$286.12
Day Low
$283.10
Day High
$293.08
52W Low
$283.10
52W High
$495.55
Market Cap
$39.06B
Volume
0.99M
| 13 Apr 2026 |
| Truist Securities |
| Buy |
| Buy |
| maintain |
| 25 Mar 2026 | Chardan Capital | Buy | Buy | maintain |
| 25 Mar 2026 | HC Wainwright & Co. | Buy | Buy | maintain |
| 16 Mar 2026 | Jefferies | Buy | Hold | downgrade |
| 18 Feb 2026 | HC Wainwright & Co. | Buy | Buy | maintain |
| 17 Feb 2026 | Canaccord Genuity | Buy | Buy | maintain |
| 17 Feb 2026 | Freedom Capital Markets | Hold | Buy | upgrade |